TATA Health (01255.HK) releases mid-year performance report for 2024, with a net loss attributable to shareholders of 5.13 million Hong Kong dollars, a 58.38% decrease compared to the same period last year.

The Zhitong Finance and Economics APP reported that Tata Health (01255.HK) released its performance for the six months ending June 30, 2024. During this period, the group's revenue was 72.309 million Hong Kong dollars, a decrease of 30.56% compared to the same period last year. The company's owners recorded a net loss of 5.13 million Hong Kong dollars, a decrease of 58.38% compared to last year, with a basic loss per share of 0.02 Hong Kong dollars.